Aspire Biopharma Holdings (ASBP) Net Income Growth (1y) (2025 - 2026)

Aspire Biopharma Holdings (ASBP) Net Income Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Oculis Holding AG 66,831.58 Bn 66,831.30 Bn - -0.46%
2 Nanobiotix 1,916.61 Bn 1,916.55 Bn - -
3 Akari Therapeutics 976.78 Bn 976.78 Bn - -
4 BeOne Medicines 471.48 Bn 466.69 Bn 1.35 Bn 17,802.13%
5 Vertex Pharmaceuticals 121.78 Bn 114.53 Bn 2.59 Bn 59.59%
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn -10.08%
7 Belite Bio 63.06 Bn 63.06 Bn - -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn 63.48%
9 Alnylam Pharmaceuticals 37.54 Bn 34.53 Bn 959.66 Mn 1,228.66%
10 Aspire Biopharma Holdings 1.10 Mn -724,996.75 5,750.00 79.78%

Historic Data

Download Data
DateValue
Mar 31, 2026 79.78%
Dec 31, 2025 -1,257.00%
Sep 30, 2025 -1,114.02%